ArticleCancer immunology research2016

Established T Cell-Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade.

Ellen Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.